Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Palisade Bio (PALI) FCF Margin (2016 - 2025)

Historic FCF Margin for Palisade Bio (PALI) over the last 14 years, with Q3 2025 value amounting to 71060.0%.

  • Palisade Bio's FCF Margin changed N/A to 71060.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 126050.0%, marking a year-over-year change of. This contributed to the annual value of 4454.8% for FY2023, which is N/A changed from last year.
  • Palisade Bio's FCF Margin amounted to 71060.0% in Q3 2025.
  • Palisade Bio's FCF Margin's 5-year high stood at 233300.0% during Q1 2025, with a 5-year trough of 1410.4% in Q1 2023.
  • Its 3-year average for FCF Margin is 78774.53%, with a median of 71060.0% in 2025.
  • Examining YoY changes over the last 5 years, Palisade Bio's FCF Margin showed a top increase of 279406500bps in 2021 and a maximum decrease of 279406500bps in 2021.
  • Over the past 3 years, Palisade Bio's FCF Margin (Quarter) stood at 73.06% in 2021, then crashed by -2031bps to 1410.4% in 2023, then surged by 5138bps to 71060.0% in 2025.
  • Its last three reported values are 71060.0% in Q3 2025, 90850.0% for Q2 2025, and 233300.0% during Q1 2025.